Innovation and healthcare amid COVID-19

The equity sell-off amid the COVID-19 coronavirus outbreak has been remarkable for its speed and severity, with all sectors negatively impacted. But as in previous downturns, healthcare is showing some resilience. For example in the US, the S&P 500 Index was down 32% from its February peak, while the S&P 500 Health Care sector declined only 24%, as at 20 March 2020.